Both in Biotechnology
Dyadic International vs Estrella Immunopharma
Over the past year DYAI returned −60.0% and ESLA returned −61.3%; their daily moves had a correlation of -0.00.
DYAI −60.0% ESLA −61.3%Growth of $1, one year, split-adjusted
| Metric | DYAI | ESLA |
|---|---|---|
| Price | $0.4660 | $0.4601 |
| Market cap | $18.7M | $20.0M |
| Today | +0.22% | +6.65% |
| 1 month | −24.1% | −34.7% |
| 6 months | −36.2% | −55.3% |
| Year to date | −50.4% | −70.5% |
| 1 year | −57.6% | −61.7% |
| Revenue growth (YoY) | −0.6% | — |
| Gross margin | −2.4% | — |
| Net margin | −221.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.9× | — |
| Net cash | -$1.9M | $146.7K |
| Dividend yield | — | — |
| Volatility (60d) | 102.2% | 76.0% |
| Short % of float | 0.8% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).